Sign in

CIK 0001706431 · Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
812730369
Phone
415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Open-market sale Chief Medical Officer sold 5,000 shares at $43.67 ($218,346)
  2. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $45.29 ($62,274)
  3. 4 Open-market sale Director sold 11,670 shares at $44.56 ($520,033)
  4. 4 Open-market sale Chief Medical Officer sold 10,000 shares at an average $41.49 ($414,874)
  5. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $42.51 ($58,451)
  6. 8-K Event Other events
  7. 4 Grant or award Director acquired 3,374 shares (grant or award)
  8. 4 Grant or award Director acquired 3,374 shares (grant or award)
  9. 4 Grant or award Director acquired 3,374 shares (grant or award)
  10. 4 Grant or award Director acquired 3,374 shares (grant or award)
  11. 4 Grant or award Director acquired 3,374 shares (grant or award)
  12. 4 Grant or award Director acquired 3,374 shares (grant or award)
  13. 4 Grant or award Director acquired 3,374 shares (grant or award)
  14. 4 Grant or award Director acquired 3,374 shares (grant or award)
  15. 4 Grant or award Director acquired 3,374 shares (grant or award)
  16. 4 Grant or award Director acquired 3,374 shares (grant or award)
  17. 4 Open-market sale Director sold 11,670 shares at an average $44.50 ($519,351)
  18. 8-K Event Material agreement · Shareholder vote results
  19. 8-K Event Other events
  20. 4 Open-market sale Director sold 10,000 shares at $43.73 ($437,275)

Page 28 of 41 · 806 filings